Psilocybin Therapy Reduces Depression Symptoms in Clinicians

A groundbreaking study highlights psilocybin’s potential to alleviate depression among COVID-19 frontline healthcare workers.

Topline

A randomized trial found that psilocybin therapy led to a 21-point reduction in depression scores for clinicians compared to niacin, marking a significant breakthrough in post-pandemic mental health care.

Study Details

During the COVID-19 pandemic, frontline clinicians faced immense psychological strain, leading to burnout, depression, and post-tra…